European Journal of Inflammation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.1 | Q4 | 7.1% | 0.300 | Q4 | 43.4% |
| 2024 | 0.8 | Q4 | 6.0% | 0.260 | Q4 | 40.6% |
| 2023 | 0.6 | Q4 | 4.1% | 0.213 | Q4 | 37.3% |
| 2022 | 0.7 | Q4 | 3.1% | 0.174 | Q4 | 33.0% |
| 2021 | 0.4 | Q4 | 15.6% | 0.165 | Q4 | 33.3% |
| 2020 | — | — | 0.219 | Q4 | 39.1% | |
| 2019 | — | — | 0.197 | Q4 | 38.1% | |
| 2018 | — | — | 0.147 | Q4 | 21.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1721-727X
ISSN
2058-7392
region
Western Europe
coverage
2004-2026